Trending Stock News

EPS for Magellan Health, Inc. (MGLN) Expected At $2.19; Kinross Gold (TSE:K) Had 3 Analysts Last Week

Analysts expect Magellan Health, Inc. (NASDAQ:MGLN) to report $2.19 EPS on February, 27 before the open.They anticipate $0.52 EPS change or 31.14% from last quarter’s $1.67 EPS. MGLN’s profit would be $52.61 million giving it 11.00 P/E if the $2.19 EPS is correct. After having $1.52 EPS previously, Magellan Health, Inc.’s analysts see 44.08% EPS growth. The stock increased 1.47% or $1.4 during the last trading session, reaching $96.4. About 60,472 shares traded. Magellan Health, Inc. (NASDAQ:MGLN) has risen 5.31% since February 22, 2017 and is uptrending. It has underperformed by 11.39% the S&P500.

Among 6 analysts covering Kinross Gold Corporation (TSE:K), 3 have Buy rating, 1 Sell and 2 Hold. Therefore 50% are positive. Kinross Gold Corporation had 23 analyst reports since September 1, 2015 according to SRatingsIntel. The stock of Kinross Gold Corporation (TSE:K) earned “Neutral” rating by JP Morgan on Thursday, February 4. The company was maintained on Monday, December 11 by Desjardins Securities. As per Friday, August 26, the company rating was maintained by RBC Capital Markets. RBC Capital Markets maintained Kinross Gold Corporation (TSE:K) rating on Friday, September 23. RBC Capital Markets has “Outperform” rating and $10 target. Scotia Capital maintained Kinross Gold Corporation (TSE:K) rating on Friday, February 17. Scotia Capital has “Sector Perform” rating and $4 target. The firm has “Sector Perform” rating by Scotia Capital given on Thursday, November 3. BMO Capital Markets upgraded Kinross Gold Corporation (TSE:K) on Monday, May 29 to “Outperform” rating. RBC Capital Markets upgraded it to “Sector Perform” rating and $3.40 target in Tuesday, November 24 report. The company was maintained on Friday, May 5 by Scotia Capital. See Kinross Gold Corporation (TSE:K) latest ratings:

11/12/2017 Broker: Desjardins Securities Rating: Sell Maintain
20/10/2017 Broker: Canaccord Genuity Rating: Old Target: $7.75 New Target: $8.00 Target Up
29/09/2017 Broker: Canaccord Genuity Rating: Old Target: $7.00 New Target: $7.75 Target Up

Since September 5, 2017, it had 0 insider purchases, and 20 sales for $25.03 million activity. The insider Kamal Mostafa sold 2,190 shares worth $177,540. WEST JEFFREY N had sold 18,511 shares worth $1.60M. 17,443 shares valued at $1.68 million were sold by Rubin Jonathan N on Tuesday, January 2. SMITH BARRY M sold $1.33M worth of Magellan Health, Inc. (NASDAQ:MGLN) on Thursday, February 1. The insider GREGOIRE DANIEL N sold $1.70M.

Investors sentiment increased to 0.98 in 2017 Q3. Its up 0.10, from 0.88 in 2017Q2. It is positive, as 12 investors sold Magellan Health, Inc. shares while 76 reduced holdings. 32 funds opened positions while 54 raised stakes. 22.27 million shares or 3.44% more from 21.53 million shares in 2017Q2 were reported. Goldman Sachs Gru reported 0.01% in Magellan Health, Inc. (NASDAQ:MGLN). Profund Advsr Lc invested in 0.02% or 4,490 shares. 207 were accumulated by Us Bancorp De. Legal & General Gru Public Limited Company reported 68,940 shares or 0% of all its holdings. Aviance Capital Ptnrs Lc holds 22,200 shares or 0.65% of its portfolio. 33,401 are held by Martingale Asset Mgmt Ltd Partnership. Cornerstone Mgmt Ltd Company holds 0.01% of its portfolio in Magellan Health, Inc. (NASDAQ:MGLN) for 10,100 shares. Oak Associate Oh owns 0.04% invested in Magellan Health, Inc. (NASDAQ:MGLN) for 6,885 shares. Aqr Capital Mngmt Ltd Company reported 47,889 shares. Dean Management has invested 1.56% of its portfolio in Magellan Health, Inc. (NASDAQ:MGLN). Automobile Association holds 0.01% of its portfolio in Magellan Health, Inc. (NASDAQ:MGLN) for 21,900 shares. The Illinois-based Balyasny Asset Mgmt Ltd Liability Corporation has invested 0% in Magellan Health, Inc. (NASDAQ:MGLN). 39,966 were reported by California State Teachers Retirement System. Dupont Mngmt invested 0.01% in Magellan Health, Inc. (NASDAQ:MGLN). Systematic Mgmt Ltd Partnership holds 0.03% in Magellan Health, Inc. (NASDAQ:MGLN) or 18,885 shares.

Among 5 analysts covering Magellan Health (NASDAQ:MGLN), 3 have Buy rating, 1 Sell and 1 Hold. Therefore 60% are positive. Magellan Health had 21 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Buy” rating by KeyBanc Capital Markets given on Friday, December 1. The firm has “Buy” rating given on Friday, June 23 by Leerink Swann. Barclays Capital maintained it with “Underweight” rating and $69 target in Wednesday, November 23 report. The stock of Magellan Health, Inc. (NASDAQ:MGLN) has “Overweight” rating given on Friday, July 14 by KeyBanc Capital Markets. The stock has “Hold” rating by Raymond James on Friday, December 1. Jefferies maintained it with “Buy” rating and $94.0 target in Tuesday, September 5 report. Jefferies maintained the stock with “Buy” rating in Wednesday, June 7 report. Jefferies maintained the stock with “Buy” rating in Friday, December 1 report. On Friday, May 20 the stock rating was maintained by Jefferies with “Buy”. As per Wednesday, January 6, the company rating was downgraded by Barclays Capital.

Magellan Health, Inc. engages in the healthcare management business in the United States. The company has market cap of $2.32 billion. The company's Healthcare segment engages in the management of behavioral healthcare services and employee assistance program services; management of other specialty areas, including diagnostic imaging and musculoskeletal management; and the integrated management of physical, behavioral, and pharmaceutical healthcare for special populations comprising individuals with serious mental illness, dual eligibles, long-term services and supports, and other populations with unique and often complex healthcare needs. It has a 25.52 P/E ratio. This segment provides its healthcare services through its comprehensive network of medical and behavioral health professionals, clinics, hospitals, and ancillary service providers.

Kinross Gold Corporation, together with its subsidiaries, engages in the acquisition, exploration, and development of gold properties. The company has market cap of $5.86 billion. The companyÂ’s gold production and exploration activities are carried out principally in Canada, the United States, the Russian Federation, Brazil, Chile, Ghana, and Mauritania. It has a 13.43 P/E ratio. It also produces and sells silver; and explores for copper.

Since December 13, 2017, it had 0 insider purchases, and 2 selling transactions for $165.18 billion activity. $165.17B worth of Kinross Gold Corporation (TSE:K) was sold by KELLOGG W K FOUNDATION TRUST on Wednesday, December 13.

Leave a Reply

Your email address will not be published. Required fields are marked *